A detailed history of Mcf Advisors LLC transactions in Amgen Inc stock. As of the latest transaction made, Mcf Advisors LLC holds 4,473 shares of AMGN stock, worth $1.41 Million. This represents 0.1% of its overall portfolio holdings.

Number of Shares
4,473
Previous 4,511 0.84%
Holding current value
$1.41 Million
Previous $1.41 Million 2.27%
% of portfolio
0.1%
Previous 0.11%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 24, 2024

SELL
$309.38 - $337.38 $11,756 - $12,820
-38 Reduced 0.84%
4,473 $1.44 Million
Q2 2024

Aug 05, 2024

BUY
$262.75 - $319.31 $53,338 - $64,819
203 Added 4.71%
4,511 $1.41 Million
Q1 2024

Apr 16, 2024

BUY
$268.87 - $324.56 $39,255 - $47,385
146 Added 3.51%
4,308 $1.22 Million
Q4 2023

Feb 01, 2024

BUY
$255.7 - $288.46 $17,387 - $19,615
68 Added 1.66%
4,162 $1.2 Million
Q3 2023

Oct 19, 2023

BUY
$218.65 - $271.46 $15,305 - $19,002
70 Added 1.74%
4,094 $1.1 Million
Q2 2023

Jul 24, 2023

BUY
$214.27 - $253.37 $4,499 - $5,320
21 Added 0.52%
4,024 $893,000
Q1 2023

Apr 18, 2023

SELL
$225.79 - $275.2 $47,415 - $57,792
-210 Reduced 4.98%
4,003 $967,000
Q4 2022

Jan 31, 2023

BUY
$229.03 - $291.01 $112,911 - $143,467
493 Added 13.25%
4,213 $1.11 Million
Q3 2022

Nov 09, 2022

BUY
$224.46 - $253.15 $164,753 - $185,812
734 Added 24.58%
3,720 $839,000
Q2 2022

Aug 11, 2022

SELL
$230.71 - $256.74 $3,460 - $3,851
-15 Reduced 0.5%
2,986 $726,000
Q1 2022

May 05, 2022

BUY
$219.27 - $242.57 $658,029 - $727,952
3,001 New
3,001 $725,000
Q4 2021

Feb 14, 2022

SELL
$198.88 - $227.6 $493,023 - $564,220
-2,479 Closed
0 $0
Q3 2021

Nov 12, 2021

BUY
$212.27 - $248.7 $143,919 - $168,618
678 Added 37.65%
2,479 $527,000
Q2 2021

Aug 10, 2021

BUY
$233.58 - $259.14 $101,140 - $112,207
433 Added 31.65%
1,801 $439,000
Q1 2021

May 13, 2021

BUY
$221.91 - $258.6 $37,502 - $43,703
169 Added 14.1%
1,368 $340,000
Q3 2020

Nov 12, 2020

BUY
$234.65 - $260.95 $18,068 - $20,093
77 Added 6.86%
1,199 $305,000
Q2 2018

Jul 20, 2018

SELL
$166.05 - $186.51 $12,785 - $14,361
-77 Reduced 6.42%
1,122 $207,000
Q3 2017

Oct 30, 2017

BUY
$167.29 - $191.0 $200,580 - $229,009
1,199
1,199 $224,000

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $169B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Mcf Advisors LLC Portfolio

Follow Mcf Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mcf Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Mcf Advisors LLC with notifications on news.